Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00507546 · ClinicalTrials.gov registry record · Phase 4
Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia
A Phase 4 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT00507546 is a Phase 4 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 12 participants.
The verdict
NCT00507546, a Phase 4 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if replacing melatonin function with a melatonin agonist (ramelteon) in individuals that lack endogenous melatonin production (tetraplegia) helps to alleviate self-reported sleep disruption.
Interventions
- DRUG Placebo
- DRUG Ramelteon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2007-07 |
| Est. Completion | 2011-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00507546
The ClinicalTrials.gov registry entry for NCT00507546 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00507546 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00507546 about?
NCT00507546 is a clinical study titled "Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia". The purpose of this study is to determine if replacing melatonin function with a melatonin agonist (ramelteon) in individuals that lack endogenous melatonin production (tetraplegia) helps to alleviate self-reported sleep disruption.
What is the current status of trial NCT00507546?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2007-07. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00507546?
The interventions under investigation include: Placebo (DRUG), Ramelteon (DRUG).
Who is sponsoring clinical trial NCT00507546?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.